表纸
市场调查报告书

人乳寡糖 (HMO)的全球市场:趋势分析·预测

Global Human Milk Oligosaccharides (HMO) Market Analysis & Trends - Industry Forecast to 2025

出版商 Accuray Research 商品编码 470899
出版日期 内容资讯 英文 185 Pages
商品交期: 2-3个工作天内
价格
Back to Top
人乳寡糖 (HMO)的全球市场:趋势分析·预测 Global Human Milk Oligosaccharides (HMO) Market Analysis & Trends - Industry Forecast to 2025
出版日期: 2017年02月01日内容资讯: 英文 185 Pages
简介

本报告提供全球人乳寡糖 (HMO)的市场调查,提供您市场概要与主要趋势,产品及用途分析,相关法律,对市场成长的各种影响因素及市场机会分析,产品·用途·类型·地区/各主要国家趋势与市场规模的变化与预测,企业及企业间主要的配合措施,并汇整主要企业的简介等资讯。

第1章 市场概要

  • 调查手法
  • 市场趋势
  • 法律规章上的影响因素
  • 终端用户分析
  • 产品分析
  • 用途分析
  • 策略基准
  • 市场机会分析

第2章 摘要整理

第3章 市场概要

  • 目前趋势
  • 成长推进因素
  • 阻碍成长要素
  • 产业的魅力

第4章 市场分析·预测:各产品

  • 乳糖-N-新四糖 (LNnT)
  • 乳糖-N-四糖 (LNT)
  • 2'-岩藻糖基乳糖 (2'FL)
  • 3'-岩藻糖基乳糖 (3'FL)
  • 3'-唾液乳糖 (3'SL)
  • 6'-唾液乳糖 (6'SL)

第5章 市场分析·预测:各用途

  • 食品·饮料
  • 食品添加物
  • 人·动物用健康成分
  • 婴幼儿配方奶粉

第6章 市场分析·预测:各类型

  • 中性
  • 酸性

第7章 市场分析·预测:各地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 英国
    • 其他
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 其他
  • 中东
    • 沙乌地阿拉伯
    • UAE
    • 其他
  • 南美
    • 阿根廷
    • 巴西
    • 其他
  • 其他地区
    • 非洲
    • 加勒比海各国

第8章 企业的主要的活动

  • M&A
  • 联盟·JV·合作·协定
  • 产品的投入·扩张
  • 其他

第9章 主要企业

目录

The Global Human Milk Oligosaccharides (HMO) Market is poised to grow at a CAGR of around xx% over the next decade to reach approximately $xx million by 2025.

This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America

  • US
  • Canada
  • Mexico

Europe

  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • New Zealand
  • Rest of Asia

Middle East

  • Saudi Arabia
  • UAE
  • Rest of Middle East

Latin America

  • Argentina
  • Brazil
  • Rest of Latin America

Rest of the World

  • Africa
  • Caribbean

Report Highlights:

  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2025, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2025
  • Market opportunities and recommendations for new investments

Table of Contents

1 Market Outline

  • 1.1 Research Methodology
    • 1.1.1 Research Approach & Sources
  • 1.2 Market Trends
  • 1.3 Regulatory Factors
  • 1.4 Product Analysis
  • 1.5 Application Analysis
  • 1.6 Strategic Benchmarking
  • 1.7 Opportunity Analysis

2 Executive Summary

3 Market Overview

  • 3.1 Current Trends
    • 3.1.1 Increase in intake of dietary supplements
    • 3.1.2 More concerns arising towards Gut Health
    • 3.1.3 Advanced technological developments in Human Milk Oligosaccharides (HMO)
    • 3.1.4 Growth Opportunities/Investment Opportunities
  • 3.2 Drivers
  • 3.3 Constraints
  • 3.4 Industry Attractiveness
    • 3.4.1 Bargaining power of suppliers
    • 3.4.2 Bargaining power of buyers
    • 3.4.3 Threat of substitutes
    • 3.4.4 Threat of new entrants
    • 3.4.5 Competitive rivalry

4 Human Milk Oligosaccharides (HMO) Market, By Product

  • 4.1 Lacto-N-neotetraose (LNnT)
    • 4.1.1 Lacto-N-neotetraose (LNnT) Market Forecast to 2025 (US$ MN)
  • 4.2 Lacto-N-tetraose (LNT)
    • 4.2.1 Lacto-N-tetraose (LNT) Market Forecast to 2025 (US$ MN)
  • 4.3 2'-Fucosyllactose (2'FL)
    • 4.3.1 2'-Fucosyllactose (2'FL) Market Forecast to 2025 (US$ MN)
  • 4.4 3'-Fucosyllactose (3'FL)
    • 4.4.1 3'-Fucosyllactose (3'FL) Market Forecast to 2025 (US$ MN)
  • 4.5 3'-Sialyllactose (3'SL)
    • 4.5.1 3'-Sialyllactose (3'SL) Market Forecast to 2025 (US$ MN)
  • 4.6 6'-Sialyllactose (6'SL)
    • 4.6.1 6'-Sialyllactose (6'SL) Market Forecast to 2025 (US$ MN)

5 Human Milk Oligosaccharides (HMO) Market, By Applications

  • 5.1 Food & beverages
    • 5.1.1 Food & beverages Market Forecast to 2025 (US$ MN)
  • 5.2 Food supplements
    • 5.2.1 Food supplements Market Forecast to 2025 (US$ MN)
  • 5.3 Health ingredients for human and animal
    • 5.3.1 Health ingredients for human and animal Market Forecast to 2025 (US$ MN)
  • 5.4 Infant formulas
    • 5.4.1 Infant formulas Market Forecast to 2025 (US$ MN)

6 Human Milk Oligosaccharides (HMO) Market, By Type

  • 6.1 Nuetral
    • 6.1.1 Nuetral Market Forecast to 2025 (US$ MN)
  • 6.2 Acidic
    • 6.2.1 Acidic Market Forecast to 2025 (US$ MN)

7 Human Milk Oligosaccharides (HMO) Market, By Geography

  • 7.1 North America
    • 7.1.1 North America Market Forecast by Countries to 2025 (US$ MN)
      • 7.1.1.1 US
      • 7.1.1.2 Canada
      • 7.1.1.3 Mexico
  • 7.2 Europe
    • 7.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)
      • 7.2.1.1 France
      • 7.2.1.2 Germany
      • 7.2.1.3 Italy
      • 7.2.1.4 Spain
      • 7.2.1.5 U.K.
      • 7.2.1.6 Rest of Europe
  • 7.3 Asia Pacific
    • 7.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)
      • 7.3.1.1 Japan
      • 7.3.1.2 China
      • 7.3.1.3 India
      • 7.3.1.4 Australia
      • 7.3.1.5 New Zealand
      • 7.3.1.6 Rest of APAC
  • 7.4 Middle East
    • 7.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)
      • 7.4.1.1 Saudi Arabia
      • 7.4.1.2 UAE
      • 7.4.1.3 Rest of Middle East
  • 7.5 Latin America
    • 7.5.1 Latin America Market Forecast by Countries to 2025 (US$ MN)
      • 7.5.1.1 Argentina
      • 7.5.1.2 Brazil
      • 7.5.1.3 Rest of Latin America
  • 7.6 Rest of the World (RoW)
    • 7.6.1 RoW Market Forecast by Countries to 2025 (US$ MN)
      • 7.6.1.1 Africa
      • 7.6.1.2 Caribbean

8 Key Player Activities

  • 8.1 Mergers & Acquisitions
  • 8.2 Partnerships, Joint Venture's, Collaborations and Agreements
  • 8.3 Product Launch & Expansions
  • 8.4 Other Activities

9 Leading Companies

  • 9.1 Elicityl S.A.
  • 9.2 Glycom A/S
  • 9.3 Glycosyn LLC
  • 9.4 Inbiose NV
  • 9.5 Jennewein Biotechnologie GmbH
  • 9.6 Medolac Laboratories
  • 9.7 ZuChem Inc.
  • 9.8 Dextra Laboratories

List of Tables

  • Table 1 Global Human Milk Oligosaccharides (HMO) Market By Region, Market Forecast (2013-2025) (US $MN)
  • Table 2 Global Human Milk Oligosaccharides (HMO) Market By Product, Market Forecast (2013-2025) (US $MN)
  • Table 3 Global Human Milk Oligosaccharides (HMO) Market By Lacto-N-neotetraose (LNnT), Market Forecast (2013-2025) (US $MN)
  • Table 4 Global Human Milk Oligosaccharides (HMO) Market By Lacto-N-tetraose (LNT), Market Forecast (2013-2025) (US $MN)
  • Table 5 Global Human Milk Oligosaccharides (HMO) Market By 2'-Fucosyllactose (2'FL), Market Forecast (2013-2025) (US $MN)
  • Table 6 Global Human Milk Oligosaccharides (HMO) Market By 3'-Fucosyllactose (3'FL), Market Forecast (2013-2025) (US $MN)
  • Table 7 Global Human Milk Oligosaccharides (HMO) Market By 3'-Sialyllactose (3'SL), Market Forecast (2013-2025) (US $MN)
  • Table 8 Global Human Milk Oligosaccharides (HMO) Market By 6'-Sialyllactose (6'SL), Market Forecast (2013-2025) (US $MN)
  • Table 9 Global Human Milk Oligosaccharides (HMO) Market By Applications, Market Forecast (2013-2025) (US $MN)
  • Table 10 Global Human Milk Oligosaccharides (HMO) Market By Food & beverages, Market Forecast (2013-2025) (US $MN)
  • Table 11 Global Human Milk Oligosaccharides (HMO) Market By Food supplements, Market Forecast (2013-2025) (US $MN)
  • Table 12 Global Human Milk Oligosaccharides (HMO) Market By Health ingredients for human and animal, Market Forecast (2013-2025) (US $MN)
  • Table 13 Global Human Milk Oligosaccharides (HMO) Market By Infant formulas, Market Forecast (2013-2025) (US $MN)
  • Table 14 Global Human Milk Oligosaccharides (HMO) Market By Type, Market Forecast (2013-2025) (US $MN)
  • Table 15 Global Human Milk Oligosaccharides (HMO) Market By Nuetral, Market Forecast (2013-2025) (US $MN)
  • Table 16 Global Human Milk Oligosaccharides (HMO) Market By Acidic, Market Forecast (2013-2025) (US $MN)
  • Table 17 North America Human Milk Oligosaccharides (HMO) Market By Country, Market Forecast (2013-2025) (US $MN)
  • Table 18 North America Human Milk Oligosaccharides (HMO) Market By Product, Market Forecast (2013-2025) (US $MN)
  • Table 19 North America Human Milk Oligosaccharides (HMO) Market By Lacto-N-neotetraose (LNnT), Market Forecast (2013-2025) (US $MN)
  • Table 20 North America Human Milk Oligosaccharides (HMO) Market By Lacto-N-tetraose (LNT), Market Forecast (2013-2025) (US $MN)
  • Table 21 North America Human Milk Oligosaccharides (HMO) Market By 2'-Fucosyllactose (2'FL), Market Forecast (2013-2025) (US $MN)
  • Table 22 North America Human Milk Oligosaccharides (HMO) Market By 3'-Fucosyllactose (3'FL), Market Forecast (2013-2025) (US $MN)
  • Table 23 North America Human Milk Oligosaccharides (HMO) Market By 3'-Sialyllactose (3'SL), Market Forecast (2013-2025) (US $MN)
  • Table 24 North America Human Milk Oligosaccharides (HMO) Market By 6'-Sialyllactose (6'SL), Market Forecast (2013-2025) (US $MN)
  • Table 25 North America Human Milk Oligosaccharides (HMO) Market By Applications, Market Forecast (2013-2025) (US $MN)
  • Table 26 North America Human Milk Oligosaccharides (HMO) Market By Food & beverages, Market Forecast (2013-2025) (US $MN)
  • Table 27 North America Human Milk Oligosaccharides (HMO) Market By Food supplements, Market Forecast (2013-2025) (US $MN)
  • Table 28 North America Human Milk Oligosaccharides (HMO) Market By Health ingredients for human and animal, Market Forecast (2013-2025) (US $MN)
  • Table 29 North America Human Milk Oligosaccharides (HMO) Market By Infant formulas, Market Forecast (2013-2025) (US $MN)
  • Table 30 North America Human Milk Oligosaccharides (HMO) Market By Type, Market Forecast (2013-2025) (US $MN)
  • Table 31 North America Human Milk Oligosaccharides (HMO) Market By Nuetral, Market Forecast (2013-2025) (US $MN)
  • Table 32 North America Human Milk Oligosaccharides (HMO) Market By Acidic, Market Forecast (2013-2025) (US $MN)
  • Table 33 Europe Human Milk Oligosaccharides (HMO) Market By Country, Market Forecast (2013-2025) (US $MN)
  • Table 34 Europe Human Milk Oligosaccharides (HMO) Market By Product, Market Forecast (2013-2025) (US $MN)
  • Table 35 Europe Human Milk Oligosaccharides (HMO) Market By Lacto-N-neotetraose (LNnT), Market Forecast (2013-2025) (US $MN)
  • Table 36 Europe Human Milk Oligosaccharides (HMO) Market By Lacto-N-tetraose (LNT), Market Forecast (2013-2025) (US $MN)
  • Table 37 Europe Human Milk Oligosaccharides (HMO) Market By 2'-Fucosyllactose (2'FL), Market Forecast (2013-2025) (US $MN)
  • Table 38 Europe Human Milk Oligosaccharides (HMO) Market By 3'-Fucosyllactose (3'FL), Market Forecast (2013-2025) (US $MN)
  • Table 39 Europe Human Milk Oligosaccharides (HMO) Market By 3'-Sialyllactose (3'SL), Market Forecast (2013-2025) (US $MN)
  • Table 40 Europe Human Milk Oligosaccharides (HMO) Market By 6'-Sialyllactose (6'SL), Market Forecast (2013-2025) (US $MN)
  • Table 41 Europe Human Milk Oligosaccharides (HMO) Market By Applications, Market Forecast (2013-2025) (US $MN)
  • Table 42 Europe Human Milk Oligosaccharides (HMO) Market By Food & beverages, Market Forecast (2013-2025) (US $MN)
  • Table 43 Europe Human Milk Oligosaccharides (HMO) Market By Food supplements, Market Forecast (2013-2025) (US $MN)
  • Table 44 Europe Human Milk Oligosaccharides (HMO) Market By Health ingredients for human and animal, Market Forecast (2013-2025) (US $MN)
  • Table 45 Europe Human Milk Oligosaccharides (HMO) Market By Infant formulas, Market Forecast (2013-2025) (US $MN)
  • Table 46 Europe Human Milk Oligosaccharides (HMO) Market By Type, Market Forecast (2013-2025) (US $MN)
  • Table 47 Europe Human Milk Oligosaccharides (HMO) Market By Nuetral, Market Forecast (2013-2025) (US $MN)
  • Table 48 Europe Human Milk Oligosaccharides (HMO) Market By Acidic, Market Forecast (2013-2025) (US $MN)
  • Table 49 Asia Pacific Human Milk Oligosaccharides (HMO) Market By Country, Market Forecast (2013-2025) (US $MN)
  • Table 50 Asia Pacific Human Milk Oligosaccharides (HMO) Market By Product, Market Forecast (2013-2025) (US $MN)
  • Table 51 Asia Pacific Human Milk Oligosaccharides (HMO) Market By Lacto-N-neotetraose (LNnT), Market Forecast (2013-2025) (US $MN)
  • Table 52 Asia Pacific Human Milk Oligosaccharides (HMO) Market By Lacto-N-tetraose (LNT), Market Forecast (2013-2025) (US $MN)
  • Table 53 Asia Pacific Human Milk Oligosaccharides (HMO) Market By 2'-Fucosyllactose (2'FL), Market Forecast (2013-2025) (US $MN)
  • Table 54 Asia Pacific Human Milk Oligosaccharides (HMO) Market By 3'-Fucosyllactose (3'FL), Market Forecast (2013-2025) (US $MN)
  • Table 55 Asia Pacific Human Milk Oligosaccharides (HMO) Market By 3'-Sialyllactose (3'SL), Market Forecast (2013-2025) (US $MN)
  • Table 56 Asia Pacific Human Milk Oligosaccharides (HMO) Market By 6'-Sialyllactose (6'SL), Market Forecast (2013-2025) (US $MN)
  • Table 57 Asia Pacific Human Milk Oligosaccharides (HMO) Market By Applications, Market Forecast (2013-2025) (US $MN)
  • Table 58 Asia Pacific Human Milk Oligosaccharides (HMO) Market By Food & beverages, Market Forecast (2013-2025) (US $MN)
  • Table 59 Asia Pacific Human Milk Oligosaccharides (HMO) Market By Food supplements, Market Forecast (2013-2025) (US $MN)
  • Table 60 Asia Pacific Human Milk Oligosaccharides (HMO) Market By Health ingredients for human and animal, Market Forecast (2013-2025) (US $MN)
  • Table 61 Asia Pacific Human Milk Oligosaccharides (HMO) Market By Infant formulas, Market Forecast (2013-2025) (US $MN)
  • Table 62 Asia Pacific Human Milk Oligosaccharides (HMO) Market By Type, Market Forecast (2013-2025) (US $MN)
  • Table 63 Asia Pacific Human Milk Oligosaccharides (HMO) Market By Nuetral, Market Forecast (2013-2025) (US $MN)
  • Table 64 Asia Pacific Human Milk Oligosaccharides (HMO) Market By Acidic, Market Forecast (2013-2025) (US $MN)
  • Table 65 Middle East Human Milk Oligosaccharides (HMO) Market By Country, Market Forecast (2013-2025) (US $MN)
  • Table 66 Middle East Human Milk Oligosaccharides (HMO) Market By Product, Market Forecast (2013-2025) (US $MN)
  • Table 67 Middle East Human Milk Oligosaccharides (HMO) Market By Lacto-N-neotetraose (LNnT), Market Forecast (2013-2025) (US $MN)
  • Table 68 Middle East Human Milk Oligosaccharides (HMO) Market By Lacto-N-tetraose (LNT), Market Forecast (2013-2025) (US $MN)
  • Table 69 Middle East Human Milk Oligosaccharides (HMO) Market By 2'-Fucosyllactose (2'FL), Market Forecast (2013-2025) (US $MN)
  • Table 70 Middle East Human Milk Oligosaccharides (HMO) Market By 3'-Fucosyllactose (3'FL), Market Forecast (2013-2025) (US $MN)
  • Table 71 Middle East Human Milk Oligosaccharides (HMO) Market By 3'-Sialyllactose (3'SL), Market Forecast (2013-2025) (US $MN)
  • Table 72 Middle East Human Milk Oligosaccharides (HMO) Market By 6'-Sialyllactose (6'SL), Market Forecast (2013-2025) (US $MN)
  • Table 73 Middle East Human Milk Oligosaccharides (HMO) Market By Applications, Market Forecast (2013-2025) (US $MN)
  • Table 74 Middle East Human Milk Oligosaccharides (HMO) Market By Food & beverages, Market Forecast (2013-2025) (US $MN)
  • Table 75 Middle East Human Milk Oligosaccharides (HMO) Market By Food supplements, Market Forecast (2013-2025) (US $MN)
  • Table 76 Middle East Human Milk Oligosaccharides (HMO) Market By Health ingredients for human and animal, Market Forecast (2013-2025) (US $MN)
  • Table 77 Middle East Human Milk Oligosaccharides (HMO) Market By Infant formulas, Market Forecast (2013-2025) (US $MN)
  • Table 78 Middle East Human Milk Oligosaccharides (HMO) Market By Type, Market Forecast (2013-2025) (US $MN)
  • Table 79 Middle East Human Milk Oligosaccharides (HMO) Market By Nuetral, Market Forecast (2013-2025) (US $MN)
  • Table 80 Middle East Human Milk Oligosaccharides (HMO) Market By Acidic, Market Forecast (2013-2025) (US $MN)
  • Table 81 Latin America Human Milk Oligosaccharides (HMO) Market By Country, Market Forecast (2013-2025) (US $MN)
  • Table 82 Latin America Human Milk Oligosaccharides (HMO) Market By Product, Market Forecast (2013-2025) (US $MN)
  • Table 83 Latin America Human Milk Oligosaccharides (HMO) Market By Lacto-N-neotetraose (LNnT), Market Forecast (2013-2025) (US $MN)
  • Table 84 Latin America Human Milk Oligosaccharides (HMO) Market By Lacto-N-tetraose (LNT), Market Forecast (2013-2025) (US $MN)
  • Table 85 Latin America Human Milk Oligosaccharides (HMO) Market By 2'-Fucosyllactose (2'FL), Market Forecast (2013-2025) (US $MN)
  • Table 86 Latin America Human Milk Oligosaccharides (HMO) Market By 3'-Fucosyllactose (3'FL), Market Forecast (2013-2025) (US $MN)
  • Table 87 Latin America Human Milk Oligosaccharides (HMO) Market By 3'-Sialyllactose (3'SL), Market Forecast (2013-2025) (US $MN)
  • Table 88 Latin America Human Milk Oligosaccharides (HMO) Market By 6'-Sialyllactose (6'SL), Market Forecast (2013-2025) (US $MN)
  • Table 89 Latin America Human Milk Oligosaccharides (HMO) Market By Applications, Market Forecast (2013-2025) (US $MN)
  • Table 90 Latin America Human Milk Oligosaccharides (HMO) Market By Food & beverages, Market Forecast (2013-2025) (US $MN)
  • Table 91 Latin America Human Milk Oligosaccharides (HMO) Market By Food supplements, Market Forecast (2013-2025) (US $MN)
  • Table 92 Latin America Human Milk Oligosaccharides (HMO) Market By Health ingredients for human and animal, Market Forecast (2013-2025) (US $MN)
  • Table 93 Latin America Human Milk Oligosaccharides (HMO) Market By Infant formulas, Market Forecast (2013-2025) (US $MN)
  • Table 94 Latin America Human Milk Oligosaccharides (HMO) Market By Type, Market Forecast (2013-2025) (US $MN)
  • Table 95 Latin America Human Milk Oligosaccharides (HMO) Market By Nuetral, Market Forecast (2013-2025) (US $MN)
  • Table 96 Latin America Human Milk Oligosaccharides (HMO) Market By Acidic, Market Forecast (2013-2025) (US $MN)
  • Table 97 RoW Human Milk Oligosaccharides (HMO) Market By Country, Market Forecast (2013-2025) (US $MN)
  • Table 98 RoW Human Milk Oligosaccharides (HMO) Market By Product, Market Forecast (2013-2025) (US $MN)
  • Table 99 RoW Human Milk Oligosaccharides (HMO) Market By Lacto-N-neotetraose (LNnT), Market Forecast (2013-2025) (US $MN)
  • Table 100 RoW Human Milk Oligosaccharides (HMO) Market By Lacto-N-tetraose (LNT), Market Forecast (2013-2025) (US $MN)
  • Table 101 RoW Human Milk Oligosaccharides (HMO) Market By 2'-Fucosyllactose (2'FL), Market Forecast (2013-2025) (US $MN)
  • Table 102 RoW Human Milk Oligosaccharides (HMO) Market By 3'-Fucosyllactose (3'FL), Market Forecast (2013-2025) (US $MN)
  • Table 103 RoW Human Milk Oligosaccharides (HMO) Market By 3'-Sialyllactose (3'SL), Market Forecast (2013-2025) (US $MN)
  • Table 104 RoW Human Milk Oligosaccharides (HMO) Market By 6'-Sialyllactose (6'SL), Market Forecast (2013-2025) (US $MN)
  • Table 105 RoW Human Milk Oligosaccharides (HMO) Market By Applications, Market Forecast (2013-2025) (US $MN)
  • Table 106 RoW Human Milk Oligosaccharides (HMO) Market By Food & beverages, Market Forecast (2013-2025) (US $MN)
  • Table 107 RoW Human Milk Oligosaccharides (HMO) Market By Food supplements, Market Forecast (2013-2025) (US $MN)
  • Table 108 RoW Human Milk Oligosaccharides (HMO) Market By Health ingredients for human and animal, Market Forecast (2013-2025) (US $MN)
  • Table 109 RoW Human Milk Oligosaccharides (HMO) Market By Infant formulas, Market Forecast (2013-2025) (US $MN)
  • Table 110 RoW Human Milk Oligosaccharides (HMO) Market By Type, Market Forecast (2013-2025) (US $MN)
  • Table 111 RoW Human Milk Oligosaccharides (HMO) Market By Nuetral, Market Forecast (2013-2025) (US $MN)
  • Table 112 RoW Human Milk Oligosaccharides (HMO) Market By Acidic, Market Forecast (2013-2025) (US $MN)
Back to Top